Synergy Pharmaceuticals (FRA:S90) Price-to-Tangible-Book : (As of May. 17, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-17), Synergy Pharmaceuticals's share price is €0.00. Synergy Pharmaceuticals's Tangible Book per Share of Sep. 2018 for the quarter that ended in Sep. 2018 was €-0.33. Hence, Synergy Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Synergy Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 12 years, Synergy Pharmaceuticals's highest Price to Tangible Book Ratio was 597.69. The lowest was 0.00. And the median was 16.71.

FRA:S90's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.36
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Synergy Pharmaceuticals's share price is €0.00. Synergy Pharmaceuticals's Book Value per Sharefor the quarter that ended in Sep. 2018 was €-0.33. Hence, Synergy Pharmaceuticals's P/B Ratio of today is .

Synergy Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Synergy Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Price-to-Tangible-Book Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.26

31.59

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Synergy Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Price-to-Tangible-Book falls into.

Synergy Pharmaceuticals Price-to-Tangible-Book Calculation

Synergy Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2018 )
	=	0.00	/	-0.333
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Synergy Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines